A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/00 (2006.01) A61K 31/192 (2006.01) A61K 31/216 (2006.01) A61K 31/335 (2006.01) A61K 31/426 (2006.01) A61K 31/505 (2006.01) A61K 31/7088 (2006.01) A61P 27/06 (2006.01) C12Q 1/02 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2545777
The present invention provides compositions and methods for treating glaucoma, methods for diagnosing glaucoma, and methods for identifying agents which may be useful in the treatment of glaucoma. More specifically, the present invention describes the use of agents that modulate the expression of serum amyloid A.
La présente invention concerne des compositions et des méthodes de traitement du glaucome ainsi que des méthodes d'identification d'agents pouvant convenir pour le traitement du glaucome. Plus précisément, cette invention concerne l'emploi d'agents qui modulent l'expression de l'amyloïde sérique A.
Clark Abbot F.
Mcnatt Loretta
Wang Wan-Heng
Alcon Inc.
Smart & Biggar
LandOfFree
Use of serum amyloid a gene in diagnosis and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of serum amyloid a gene in diagnosis and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of serum amyloid a gene in diagnosis and treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1807806